- Home
- PAYS vs NBY Comparison
PAYS vs NBY Comparison
Compare PAYS & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYS
- NBY
- Stock Information
- Founded
- PAYS 2001
- NBY 2000
- Country
- PAYS United States
- NBY United States
- Employees
- PAYS N/A
- NBY N/A
- Industry
- PAYS Business Services
- NBY
- Sector
- PAYS Consumer Discretionary
- NBY
- Exchange
- PAYS Nasdaq
- NBY Nasdaq
- Market Cap
- PAYS 125.2M
- NBY 3.4M
- IPO Year
- PAYS 1998
- NBY 2007
- Fundamental
- Price
- PAYS $8.28
- NBY $0.65
- Analyst Decision
- PAYS Strong Buy
- NBY Strong Buy
- Analyst Count
- PAYS 4
- NBY 1
- Target Price
- PAYS $7.06
- NBY $0.85
- AVG Volume (30 Days)
- PAYS 909.4K
- NBY 24.4K
- Earning Date
- PAYS 07-30-2025
- NBY 08-12-2025
- Dividend Yield
- PAYS N/A
- NBY N/A
- EPS Growth
- PAYS N/A
- NBY N/A
- EPS
- PAYS 0.11
- NBY 0.57
- Revenue
- PAYS $63,792,627.00
- NBY $9,781,000.00
- Revenue This Year
- PAYS $30.03
- NBY $23.91
- Revenue Next Year
- PAYS $20.14
- NBY $32.05
- P/E Ratio
- PAYS $73.20
- NBY $1.45
- Revenue Growth
- PAYS 26.77
- NBY 20.52
- 52 Week Low
- PAYS $1.80
- NBY $0.36
- 52 Week High
- PAYS $8.28
- NBY $2.45
- Technical
- Relative Strength Index (RSI)
- PAYS 86.18
- NBY 61.92
- Support Level
- PAYS $4.72
- NBY $0.60
- Resistance Level
- PAYS $8.44
- NBY $0.70
- Average True Range (ATR)
- PAYS 0.48
- NBY 0.03
- MACD
- PAYS 0.13
- NBY 0.01
- Stochastic Oscillator
- PAYS 95.87
- NBY 64.08
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.